Position dérivée des transactions déclarées les plus récentes. Non ajustée des splits ni des conversions de classes d'actions.
| Émetteur | Actions | Source | Dernière tx | Détail |
|---|---|---|---|---|
| DISCOVERY PARTNERS INTERNATIONAL INC | 90 000 | déclaré | 30 mars 2022 | tx 8+425 000−75 000 |
| Lite Strategy, Inc. | 10 000 | déclaré | 29 sept. 2023 | tx 3+155 834 |
| Dianthus Therapeutics, Inc. /DE/ | 6 090 | déclaré | 21 mai 2026 | tx 2+31 090 |
| ACCELERON PHARMA INC | 0 | déclaré | 19 nov. 2021 | tx 36+167 558−167 558 |
| Date | Type | Émetteur | Quantité | Prix | Signaux |
|---|---|---|---|---|---|
| 21 mai 2026 | GRANT_AWARD | Dianthus Therapeutics, Inc. /DE/ | 6 090 | 0.00 USD | deriv |
| 04 mars 2025 | GRANT_AWARD | Dianthus Therapeutics, Inc. /DE/ | 25 000 | 0.00 USD | deriv |
| 29 sept. 2023 | GRANT_AWARD | Lite Strategy, Inc. | 10 000 | 0.00 USD | deriv |
| 05 juil. 2022 | GRANT_AWARD | Lite Strategy, Inc. | 87 500 | 0.00 USD | deriv |
| 30 mars 2022 | GRANT_AWARD | DISCOVERY PARTNERS INTERNATIONAL INC | 90 000 | 0.00 USD | deriv |
| 22 nov. 2021 | GRANT_AWARD | Lite Strategy, Inc. | 58 334 | 0.00 USD | deriv |
| 19 nov. 2021 | TENDER | ACCELERON PHARMA INC | 18 509 | — | |
| 19 nov. 2021 | OTHER | ACCELERON PHARMA INC | 20 896 | — | deriv |
| 19 nov. 2021 | OTHER | ACCELERON PHARMA INC | 24 334 | — | deriv |
| 19 nov. 2021 | OTHER | ACCELERON PHARMA INC | 25 000 | — | deriv |
| 19 nov. 2021 | OTHER | ACCELERON PHARMA INC | 25 500 | — | deriv |
| 27 sept. 2021 | EXERCISE | ACCELERON PHARMA INC | 5 000 | 40.61 USD | |
| 27 sept. 2021 | SALE | ACCELERON PHARMA INC | 5 000 | 175.00 USD | |
| 27 sept. 2021 | EXERCISE | ACCELERON PHARMA INC | 5 000 | 0.00 USD | deriv |
| 21 sept. 2021 | EXERCISE | ACCELERON PHARMA INC | 5 000 | 40.61 USD | |
| 21 sept. 2021 | SALE | ACCELERON PHARMA INC | 5 000 | 150.03 USD | |
| 21 sept. 2021 | EXERCISE | ACCELERON PHARMA INC | 5 000 | 0.00 USD | deriv |
| 12 févr. 2021 | TAX_WITHHOLDING | ACCELERON PHARMA INC | 887 | 130.87 USD | |
| 02 mars 2021 | SALE | ACCELERON PHARMA INC | 2 699 | 135.48 USD | |
| 02 mars 2021 | EXERCISE | ACCELERON PHARMA INC | 5 000 | 40.61 USD | |
| 02 mars 2021 | SALE | ACCELERON PHARMA INC | 1 501 | 136.24 USD | |
| 02 mars 2021 | SALE | ACCELERON PHARMA INC | 200 | 138.15 USD | |
| 02 mars 2021 | SALE | ACCELERON PHARMA INC | 600 | 137.12 USD | |
| 02 mars 2021 | EXERCISE | ACCELERON PHARMA INC | 5 000 | 0.00 USD | deriv |
| 29 janv. 2021 | GRANT_AWARD | ACCELERON PHARMA INC | 5 409 | 0.00 USD |